Generic name |
ciprofloxacin ophthalmic |
---|---|
Strength & form |
0.3% eye drop |
Special Authority criteria |
Approval period |
---|---|
Failure or intolerance to first-line agents. (e.g., aminoglycosides) |
Short term |
Practitioners in the following specialty are not required to submit a Special Authority request form for coverage: